The Azienda Ospedaliera San Giovanni Addolorata in Rome is one of the largest hospitals in central Italy; the current administrative designation refers to one of the largest and oldest hospitals in the city, commonly designated as San Giovanni hospital.

During the past decade, Complesso Ospedaliero S. Giovanni Addolorata conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 7 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complesso Ospedaliero S. Giovanni Addolorata" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 22 trials, followed by "Amgen" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complesso Ospedaliero S. Giovanni Addolorata" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Azienda Ospedaliero, Universitaria Pisana" with 1 trials as a collaborator, "BMR Genomics" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator and "Centro per la Lotta Contro l'Infarto - Fondazione Onlus" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Complesso Ospedaliero S. Giovanni Addolorata" are "Leukemia" (7 trials), "Chronic Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Abdominal Aortic Aneurysm" (2 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Complesso Ospedaliero S. Giovanni Addolorata" in a lesser frequency.

Most popular intervention types in "Complesso Ospedaliero S. Giovanni Addolorata" are "Drug" (34 trials), "Device" (7 trials), "Other" (7 trials), "Procedure" (7 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (3 trials), "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Gemcitabine" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Complesso Ospedaliero S. Giovanni Addolorata" are 55 trials for "All" genders.

Currently, there are NaN active trials in "Complesso Ospedaliero S. Giovanni Addolorata". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Complesso Ospedaliero S. Giovanni Addolorata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complesso Ospedaliero S. Giovanni Addolorata, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".

Complesso Ospedaliero S. Giovanni Addolorata has several departments that took part in Clinical trials: "UOC Gastroenterologia ed Endoscopia Digestiva" - 4 trials, "Ao San Giovanni Addolorata - Cardiologia E Riab. Cardiologica" - 2 trials